ACT CAPITAL MANAGEMENT, LLC
Q2 2026 13F Holdings
- Locationwayne, PA
- Num holdings
62
- Value ($000)
$153,064
- Date Filed 07/29/2026
- Form type13F-HR
- CIK 0001442273
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2026 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
KRYSTAL BIOTECH INC | COM | 501147102 | $16.73M | 11 % | 45,000 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | $13.79M | 9 % | 251,025 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | $12.93M | 8 % | 97,000 | ||
CHEVRON CORP | COM | 166764100 | $12.43M | 8 % | 75,000 | ||
EXXON MOBIL CORP | COM | 30231G102 | $10.73M | 7 % | 78,500 | ||
ARROWHEAD PHARMACEUTICALS INC | COM | 04280A100 | $8.97M | 6 % | 110,100 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | $8.16M | 5 % | 209,300 | ||
CELCUITY INC | COM | 15102K100 | $6.5M | 4 % | 62,150 | ||
NEKTAR THERAPEUTICS | COM NEW | 640268306 | $6.23M | 4 % | 89,300 | ||
TESLA INC | COM | 88160R101 | $4.54M | 3 % | 10,800 |
Rows Per Page
10
- 10
- 50
- 100